Table of Contents
Volume 5 | Supplement 2
Publication Date: November 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S60-S61 |
Emerging Therapies with Epidermal Growth Factor Receptor–Targeted Agents in Colorectal Cancer Edward Chu |
|
Contributions | ||
S62-S70 |
Current Status of Small-Molecule Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor in Colorectal Cancer Timothy Kuo, George A. Fisher |
|
S71-S80 |
Overview of Monoclonal Antibodies and Small Molecules Targeting the Epidermal Growth Factor Receptor Pathway in Colorectal Cancer Lorraine C. Snyder, Igor Astsaturov, Louis M. Weiner |
|
S81-S88 |
Recent Data with Anti–Epidermal Growth Factor Receptor Antibodies and Irinotecan in Colon Cancer Yu Jo Chua, David Cunningham |
|
S89-S97 |
Enhancing Oxaliplatin-Based Regimens in Colorectal Cancer by Inhibiting the Epidermal Growth Factor Receptor Pathway George P. Kim, Axel Grothey |
|
S98-S100 |
Epidermal Growth Factor Receptor–Negative Colorectal Cancer: Is There Truly Such an Entity? Leonard Saltz |
|
S101-S106 |
Management of Rash and Other Toxicities in Patients Treated with Epidermal Growth Factor Receptor–Targeted Agents Jay Rhee, Karen Oishi, Jody Garey, Edward Kim |
|